14th Alzheimer’s & Parkinson’s Drug Development Summit

February 3-5, 2026 | Boston, MA

Looking to connect with leading drug developers and discover next-generation therapeutics redefining neurodegenerative treatment? 
 
Look no further than the Alzheimer’s & Parkinson’s Drug Development Summit 2026. Now in its’ 14th year, the Alzheimer’s & Parkinson’s Drug Development Summit returns to Boston in 2026 and will unite global leaders from pharma, biotech, and academia to shape the next generation of neurodegenerative therapies. 
 
As the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical and regulatory, this hight-impact three-day event is specifically curated to explore disease progression, modification and prodromal intervention, so the next generation of therapeutics can prevent as well provide a meaningful impact to neurodegenerative patients in need. 
 
The 14th Alzheimer’s & Parkinson’s Drug Development Summit will feature: 
* 2 deep dive workshops into in vivo and in vitro modelling advancements 
* Seminar day on fluid-based biomarker innovation 
* 40+ expert speakers including industry leaders, academic KOLs and patient voices 
* Multiple tracks of content spanning discovery, preclinical, clinical and regulatory 
* 10+ hours dedicated networking time 
 
See the full event guide to discover more on why you should join us this February in Boston - https://ter.li/d2zq4l 
 
Website URL - https://ter.li/tybkyg 
Registration URL - https://ter.li/2ezoog 
 

Attending Companies

Contact information: 
Info@hansonwade.com